Anne R Carlew, William Goette, Jeffrey Schaffert, Heidi Rossetti, Laura H Lacritz
{"title":"在不同种族的样本中,比较神经心理学-精算法和临床共识法对轻度认知障碍的诊断。","authors":"Anne R Carlew, William Goette, Jeffrey Schaffert, Heidi Rossetti, Laura H Lacritz","doi":"10.1080/13854046.2025.2479013","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> Some studies show using neuropsychological-actuarial mild cognitive impairment (MCI) criteria may produce lower reversion rates (i.e. reverting from a cognitive diagnosis to no diagnosis) and higher associations with Alzheimer's disease biomarkers compared to conventional methods, but this has not been evaluated in a Hispanic sample. This study evaluated neuropsychological-actuarial MCI criteria performance in the Texas Alzheimer's Research and Care Consortium (TARCC) cohort compared to clinical-consensus diagnosis. <b>Method:</b> Data from 2,110 TARCC participants (47% Hispanic) were utilized. McNemar tests evaluated the performance of neuropsychological-actuarial versus clinical-consensus criteria in those who remained stable or converted to dementia over 3 annual visits, stratified by ethnicity (Hispanic vs. non-Hispanic). Chi-square analysis was used to compare frequencies of <i>APOE</i> ε4 allele positivity by diagnostic method. <b>Results:</b> Significantly more Hispanic participants were diagnosed with MCI using neuropsychological-actuarial criteria than were non-Hispanics, χ<sup>2</sup>(1) = 195.3, <i>p</i> < .001, <i>ϕ</i> = 0.32. Hispanic participants meeting neuropsychological-actuarial MCI criteria at baseline were more likely to revert at follow-up, χ<sup>2</sup>(1) = 10.04, <i>p</i> < .01, <i>ϕ</i> = 0.10. No differences in reversion rate were found between Hispanic and non-Hispanic individuals with clinical-consensus MCI diagnoses, χ<sup>2</sup>(1) = 0.38, <i>p</i> = .60. There was no association between <i>APOE</i> ε4 allele positivity and neuropsychological-actuarial diagnosis, while there was an association for clinical-consensus diagnoses <i>χ</i><sup>2</sup>(1) = 15.1, <i>p</i> < .001, <i>ϕ</i> = 0.09. <b>Conclusions:</b> In TARCC, the clinical-consensus MCI diagnostic method produced fewer cases of reversion compared to the neuropsychological-actuarial method, particularly in Hispanic participants. This is consistent with recent research investigating the use of the neuropsychological-actuarial method in African American/Black individuals. Caution is warranted when using neuropsychological-actuarial criteria among individuals with diverse backgrounds.</p>","PeriodicalId":55250,"journal":{"name":"Clinical Neuropsychologist","volume":" ","pages":"1-18"},"PeriodicalIF":2.7000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of the neuropsychological-actuarial and clinical-consensus approaches to diagnosis of mild cognitive impairment in an ethnically diverse sample.\",\"authors\":\"Anne R Carlew, William Goette, Jeffrey Schaffert, Heidi Rossetti, Laura H Lacritz\",\"doi\":\"10.1080/13854046.2025.2479013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> Some studies show using neuropsychological-actuarial mild cognitive impairment (MCI) criteria may produce lower reversion rates (i.e. reverting from a cognitive diagnosis to no diagnosis) and higher associations with Alzheimer's disease biomarkers compared to conventional methods, but this has not been evaluated in a Hispanic sample. This study evaluated neuropsychological-actuarial MCI criteria performance in the Texas Alzheimer's Research and Care Consortium (TARCC) cohort compared to clinical-consensus diagnosis. <b>Method:</b> Data from 2,110 TARCC participants (47% Hispanic) were utilized. McNemar tests evaluated the performance of neuropsychological-actuarial versus clinical-consensus criteria in those who remained stable or converted to dementia over 3 annual visits, stratified by ethnicity (Hispanic vs. non-Hispanic). Chi-square analysis was used to compare frequencies of <i>APOE</i> ε4 allele positivity by diagnostic method. <b>Results:</b> Significantly more Hispanic participants were diagnosed with MCI using neuropsychological-actuarial criteria than were non-Hispanics, χ<sup>2</sup>(1) = 195.3, <i>p</i> < .001, <i>ϕ</i> = 0.32. Hispanic participants meeting neuropsychological-actuarial MCI criteria at baseline were more likely to revert at follow-up, χ<sup>2</sup>(1) = 10.04, <i>p</i> < .01, <i>ϕ</i> = 0.10. No differences in reversion rate were found between Hispanic and non-Hispanic individuals with clinical-consensus MCI diagnoses, χ<sup>2</sup>(1) = 0.38, <i>p</i> = .60. There was no association between <i>APOE</i> ε4 allele positivity and neuropsychological-actuarial diagnosis, while there was an association for clinical-consensus diagnoses <i>χ</i><sup>2</sup>(1) = 15.1, <i>p</i> < .001, <i>ϕ</i> = 0.09. <b>Conclusions:</b> In TARCC, the clinical-consensus MCI diagnostic method produced fewer cases of reversion compared to the neuropsychological-actuarial method, particularly in Hispanic participants. This is consistent with recent research investigating the use of the neuropsychological-actuarial method in African American/Black individuals. Caution is warranted when using neuropsychological-actuarial criteria among individuals with diverse backgrounds.</p>\",\"PeriodicalId\":55250,\"journal\":{\"name\":\"Clinical Neuropsychologist\",\"volume\":\" \",\"pages\":\"1-18\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Neuropsychologist\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1080/13854046.2025.2479013\",\"RegionNum\":3,\"RegionCategory\":\"心理学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neuropsychologist","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1080/13854046.2025.2479013","RegionNum":3,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:一些研究表明,与传统方法相比,使用神经心理精算轻度认知障碍(MCI)标准可能产生更低的逆转率(即从认知诊断恢复到无诊断),并且与阿尔茨海默病生物标志物的相关性更高,但尚未在西班牙裔样本中进行评估。本研究评估了德克萨斯州阿尔茨海默病研究和护理联盟(TARCC)队列中神经心理精算MCI标准的表现,并与临床共识诊断进行了比较。方法:使用来自2110名TARCC参与者(47%为西班牙裔)的数据。McNemar试验评估了神经心理精算与临床共识标准在那些保持稳定或在3年以上就诊转为痴呆的患者中的表现,按种族分层(西班牙裔与非西班牙裔)。诊断方法采用卡方分析比较APOE ε4等位基因阳性频率。结果:使用神经心理精算标准诊断为MCI的西班牙裔参与者明显多于非西班牙裔参与者,χ2(1) = 195.3, p < .001, ϕ = 0.32。基线时符合神经心理精算MCI标准的西班牙裔参与者更有可能在随访时恢复,χ2(1) = 10.04, p < 0.01, ϕ = 0.10。临床一致诊断为MCI的西班牙裔和非西班牙裔患者的逆转率无差异,χ2(1) = 0.38, p = 0.60。APOE ε4等位基因阳性与神经心理精算诊断无相关性,而与临床一致诊断有相关性χ2(1) = 15.1, p φ = 0.09。结论:在TARCC中,与神经心理精算方法相比,临床共识的MCI诊断方法产生的逆转病例较少,特别是在西班牙裔参与者中。这与最近在非裔美国人/黑人中使用神经心理精算方法的研究是一致的。在不同背景的个体中使用神经心理精算标准时,需要谨慎。
Comparison of the neuropsychological-actuarial and clinical-consensus approaches to diagnosis of mild cognitive impairment in an ethnically diverse sample.
Objective: Some studies show using neuropsychological-actuarial mild cognitive impairment (MCI) criteria may produce lower reversion rates (i.e. reverting from a cognitive diagnosis to no diagnosis) and higher associations with Alzheimer's disease biomarkers compared to conventional methods, but this has not been evaluated in a Hispanic sample. This study evaluated neuropsychological-actuarial MCI criteria performance in the Texas Alzheimer's Research and Care Consortium (TARCC) cohort compared to clinical-consensus diagnosis. Method: Data from 2,110 TARCC participants (47% Hispanic) were utilized. McNemar tests evaluated the performance of neuropsychological-actuarial versus clinical-consensus criteria in those who remained stable or converted to dementia over 3 annual visits, stratified by ethnicity (Hispanic vs. non-Hispanic). Chi-square analysis was used to compare frequencies of APOE ε4 allele positivity by diagnostic method. Results: Significantly more Hispanic participants were diagnosed with MCI using neuropsychological-actuarial criteria than were non-Hispanics, χ2(1) = 195.3, p < .001, ϕ = 0.32. Hispanic participants meeting neuropsychological-actuarial MCI criteria at baseline were more likely to revert at follow-up, χ2(1) = 10.04, p < .01, ϕ = 0.10. No differences in reversion rate were found between Hispanic and non-Hispanic individuals with clinical-consensus MCI diagnoses, χ2(1) = 0.38, p = .60. There was no association between APOE ε4 allele positivity and neuropsychological-actuarial diagnosis, while there was an association for clinical-consensus diagnoses χ2(1) = 15.1, p < .001, ϕ = 0.09. Conclusions: In TARCC, the clinical-consensus MCI diagnostic method produced fewer cases of reversion compared to the neuropsychological-actuarial method, particularly in Hispanic participants. This is consistent with recent research investigating the use of the neuropsychological-actuarial method in African American/Black individuals. Caution is warranted when using neuropsychological-actuarial criteria among individuals with diverse backgrounds.
期刊介绍:
The Clinical Neuropsychologist (TCN) serves as the premier forum for (1) state-of-the-art clinically-relevant scientific research, (2) in-depth professional discussions of matters germane to evidence-based practice, and (3) clinical case studies in neuropsychology. Of particular interest are papers that can make definitive statements about a given topic (thereby having implications for the standards of clinical practice) and those with the potential to expand today’s clinical frontiers. Research on all age groups, and on both clinical and normal populations, is considered.